Continuing challenges in the capital markets have a big impact on what management should do—and what boards should ask about—when contemplating an IPO.
This edition of our biweekly newsletter for directors and investors includes articles on the SEC’s whistleblower program, the FASB’s issuance of new guidance on cash flow classification, and more.
PwC has compiled its quarterly summary of recent activities of the PCAOB, SEC, FASB and related international developments.
This quarterly publication is designed to keep directors informed about the latest accounting and financial reporting issues.
This edition is based on analysis of 4,200 annual meetings held between January 1 and June 30, 2016.
How can the audit committee help maximize the value of internal audit?
This edition of our biweekly newsletter for directors and investors includes articles on CalPERS claiming success in the 2016 proxy season, FASB asking for comments on its conceptual framework and topics for its future agenda, and more.
Boards can help companies prepare by asking management the right questions.
This edition of our biweekly newsletter for directors and investors includes articles on the CII suggesting changes to the PCAOB’s auditor’s reporting model reproposal, CalSTRS updating its Corporate Governance Principles, and more.
Do pharmaceutical and life sciences company directors have the right skills and expertise for the New Health Economy?